With regard to the reported activation of the Wnt/β-catenin signaling pathway via CCL20 in HCC, this may be a potential explanation for the impaired prognosis of high-CCL20 melanoma patients. This evidence concerns the gene CCL20 and hepatocellular carcinoma.